Investors

Insider Transactions

Date Name Title Type Sorted Ascending Shares Traded Price Range
Jan 27, 2011 goldstein joseph l Director Automatic Sell 5,401 34.67
Oct 4, 2010 goldstein joseph l Director Automatic Sell 6,848 27.45
Oct 14, 2011 goldstein joseph l Director Automatic Sell 10,000 65.00
Feb 10, 2011 goldstein joseph l Director Automatic Sell 2,239 35.27
Feb 11, 2011 goldstein joseph l Director Automatic Sell 2,761 36.66
Jul 1, 2011 goldstein joseph l Director Automatic Sell 10,000 55.91 - 56.40
Mar 9, 2011 goldstein joseph l Director Automatic Sell 3,495 39.35
Jan 19, 2012 goldstein joseph l Director Automatic Sell 10,000 80.00
Feb 14, 2012 goldstein joseph l Director Automatic Sell 15,000 110.02
Jan 10, 2012 goldstein joseph l Director Automatic Sell 20,000 74.35 - 75.00
Nov 24, 2010 goldstein joseph l Director Automatic Sell 4,331 30.06
Jan 27, 2010 kolinski stuart Officer Automatic Sell 4,359 27.00
Feb 2, 2010 kolinski stuart Officer Automatic Sell 6,913 27.16
Feb 3, 2010 kolinski stuart Officer Automatic Sell 5,401 27.66 - 28.08
Jun 3, 2010 kolinski stuart Officer Automatic Sell 6,784 30.02
Feb 2, 2010 mccorkle douglas s Officer Automatic Sell 5,875 28.00
Nov 2, 2007 mccorkle douglas s Officer Automatic Sell 6,209 21.00 - 21.03
Oct 1, 2008 mccorkle douglas s Officer Automatic Sell 5,034 21.22 - 22.16
Oct 1, 2008 mccorkle douglas s Officer Automatic Sell 4,957 21.22 - 21.60
Dec 15, 2014 mccorkle douglas s Officer Automatic Sell 1,668 410.16 - 417.34
Showing 181-200 of 887 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)